Obstructive Sleep Apnea (OSA)

DBCOND0040865Nervous System DiseasesRespiratory Tract Diseases

Obstructive Sleep Apnea (OSA) is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Obstructive Sleep Apnea · Sleep Apnea, Obstructive · Obstructive Sleep Apnea Syndrome · Obstructive Sleep Apnoea · OSAS (Obstructive Sleep Apneas Syndrome)
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0328295ICD-10G47.33SNOMED CT194441007MedDRA10029983UMLSC0520679

What you can answer from here — as of November 01, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
334Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Contraindicated drugsDrugs whose labels contraindicate them in this condition
Sign in
4Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Obstructive Sleep Apnea (OSA) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In